ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2,4,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
2,5,Eyelid retraction,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
2,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
5,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
7,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
7,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
7,4,Taeniasis,Cestode infections,Helminthic disorders,Infec,N
8,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
9,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
10,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
10,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
11,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
12,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
12,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
12,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12,4,Low density lipoprotein increased,Cholesterol analyses,Lipid analyses,Inv,N
12,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
13,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
13,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
13,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
13,4,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
14,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
14,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
16,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
17,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
17,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
17,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
17,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
18,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
18,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
19,1,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
19,2,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
20,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
21,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
21,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
22,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
22,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
23,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
24,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
25,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
26,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
26,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
27,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
27,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
28,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
28,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
29,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
29,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
30,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
31,1,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
31,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
32,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Hydrocholecystis,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
34,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
34,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
34,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
35,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
37,1,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
38,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
39,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
40,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,2,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,Y
41,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
41,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
42,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
43,2,Urge incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
44,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
46,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
47,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
48,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
49,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
50,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
51,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
52,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
53,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
54,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
54,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
55,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
55,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
55,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
55,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
56,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
56,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
57,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
57,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
58,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
58,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
58,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
58,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
58,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
58,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
58,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,2,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
59,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
60,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
62,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
62,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
62,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
63,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
63,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
64,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
64,2,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
64,3,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
65,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
65,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
65,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
66,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
67,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
67,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
67,3,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
67,4,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
67,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
68,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
68,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
68,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
68,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,1,Meniscus injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
69,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
70,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
70,2,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
70,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
71,1,Joint arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
72,1,Arteriovenous malformation,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
72,2,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
72,3,Congenital pulmonary valve atresia,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
72,4,Congenital tricuspid valve stenosis,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
72,5,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
72,6,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
72,7,Heterotaxia,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
72,8,Pulmonary arteriovenous fistula,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
72,9,Ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
72,10,Ventricular hypoplasia,Cardiac hypoplasias congenital,Cardiac and vascular disorders congenital,Cong,N
73,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
74,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
75,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
76,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
77,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
77,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
78,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
78,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
78,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
78,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
78,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
79,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
81,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
82,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
83,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
84,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
84,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
85,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
86,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
87,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
87,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
87,3,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
88,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
88,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
89,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
90,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
91,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
91,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
92,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
92,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
92,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
92,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
93,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
93,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
94,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
95,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
96,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
96,2,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
96,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
97,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
98,1,Fat redistribution,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
98,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
99,1,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
100,1,Diabetic hyperosmolar coma,Coma states,Neurological disorders NEC,Nerv,N
100,2,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
101,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
102,1,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
102,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
102,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
102,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
102,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
102,6,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
103,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
103,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
104,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
105,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
106,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
107,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
107,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
108,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
108,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
108,3,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
108,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
108,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
109,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
109,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,1,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
111,1,Congenital bladder anomaly,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
111,2,Congenital hydronephrosis,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
111,3,Congenital urethral anomaly,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
112,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
112,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
112,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
112,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
112,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
112,6,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
113,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
113,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
114,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
114,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
114,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
115,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
116,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
116,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
116,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
116,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
117,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
117,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
117,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
117,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
117,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
117,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
117,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
117,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
117,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
117,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
118,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
119,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
119,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
119,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
119,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
120,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
121,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
122,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
123,1,Delivery,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
123,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
124,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
124,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
125,1,Precocious puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
126,1,Deafness,Hearing losses,Hearing disorders,Ear,N
127,1,Precocious puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
128,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
128,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
129,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
129,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
130,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
130,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
131,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
131,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
132,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
132,2,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
132,3,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
132,4,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
132,5,Cryptorchism,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
133,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
133,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
133,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
133,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
134,1,Fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
134,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
134,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
135,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
135,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
135,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
136,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
137,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
138,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
139,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
139,2,Blood immunoglobulin E increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
139,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
139,4,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
139,5,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
139,6,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
139,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
139,8,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
139,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
139,10,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
139,11,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
139,12,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
139,13,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
139,14,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
139,15,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
139,16,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
139,17,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
139,18,Myopathy,Myopathies,Muscle disorders,Musc,N
139,19,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
139,20,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
139,21,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
139,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
139,23,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
139,24,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
139,25,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
139,26,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
139,27,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
139,28,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
140,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
141,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
141,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
141,4,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
142,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
142,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
143,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
143,2,Lactation insufficiency,Lactation disorders,Breast disorders,Repro,N
143,3,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
143,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
144,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
144,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
145,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
146,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
146,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
146,3,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
146,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
146,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
146,6,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
146,7,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
146,8,Twin pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
146,9,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
147,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
147,2,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
147,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
147,4,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
147,5,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
148,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
149,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
150,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
150,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
151,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
151,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
151,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
151,4,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
151,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
152,1,Congenital hydronephrosis,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
152,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
153,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
153,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
154,1,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
154,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,3,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
154,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
155,2,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
156,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
156,2,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
156,3,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
156,4,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
